2-Bromo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde

Catalog No. :
ACROBV335
CAS No. :
1844839-23-1
Molecular Formula :
C13H16BBrO3
Molecular Weight :
310.98

IUPAC Name:2-bromo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde

2-Bromo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$210.00Login to see priceInquiryInquiry
1g97%$524.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde
IUPAC Name2-bromo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde
MDL No.MFCD29119875
Molecular FormulaC13H16BBrO3
Molecular Weight310.98
SMILESO=CC1=C(B2OC(C)(C)C(C)(C)O2)C=CC=C1Br
InChI KeyRKHAZZZJWWJOSD-UHFFFAOYSA-N
Synonym(3-BROMO-2-FORMYLPHENYL)BORONIC ACID PINACOL ESTER;2-Bromo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde;Benzaldehyde, 2-bromo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1844839-23-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACROBV335 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACGIFP796 route compound structure diagram
    ACGIFP79667713-23-9 In Stock
  4. Then
  5. ACROBV335 route product structure diagram
    ACROBV3351844839-23-1
Inquiry

2. ACROBV335 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACROBV335 route product structure diagram
    ACROBV3351844839-23-1
Inquiry

Comments (0)